Nihon Medi-Physics Embarks on Development of New Cancer Treatment Jan. 15, 2018 Nihon Medi-Physics Co. Ltd., a radiopharmaceutical manufacturing venture equally funded by Sumitomo Chemical Co. Ltd. (TYO:4005) and GE Healthcare, will…... Please subscribe to read the full story. Subscribe Free Trial